Scientific Committee

Ruti Alon, Founder & CEO, Medstrada, Biomed 2024 Committee Chair 

Ora Dar, PhD, Senior Expert, Medical Sciences & Health Innovation, Biomed 2024 Committee Chair

Dr. Nissim Darvish, MD, PhD, Managing General Partner, Eliraz Ventures, Biomed 2024 Committee Chair

Avital Adler– PhD, Neuroscientist and Investor, Principal, aMoon Fund

Dr. Barak Azmon, MD, Director, Pres-By

Yaron Danieli, PhD, Partner, aMoon

Gilad Glick, MBA, VP JJDC MedTech, Johnson & Johnson Innovation Fund

Barry Greene, CEO, Sage Therapeutics

Iris Grossman, PhD, Chief Therapeutics Officer, Eleven Therapeutics

Yael Gruenbaum -Cohen, DMD, PhD
Partner & Head of aMoon Alpha

Avner Halperin, CEO, Sheba Medical Center

Prof. Dror Harats, MD, CEO & Director, VBL Therapeutics, Biomed 2024 Steering Committee

Dr. Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine, Regeneron

Sharon Kaplinsky, Founder & CEO, Star Tree Ventures

Prof. Anat Loewenstein, MD, Professor of Ophthalmology and Vice Dean, Tel Aviv University

Adar Makovski, PhD, Principal, Arkin Bio Ventures

Yuval Mandelbaum, MBA, CEO,  Discure Technologies

Tammy Meiron, PhD, Chief Technology Officer, FreshStart FoodTech Incubator

Shai Melcer, PhD, Head of the National Bio-convergence Program, Israel Innovation Authority

Karin Noy, PhD, Emerging Science & Innovation Lead, Pfizer 

Yanay Ofran, PhD, Co-Founder & CEO, Biolojic Design

Dr. Ofer Sharon, MD, CEO, OncoHost

Avi Viedman, Co-Founder & CEO, Nucleai

Dr. Jonathan Weyne, MD, Vice President, Ophthalmology Therapeutic Area Lead, Regeneron

Dr. Irit Yaniv, MD, MBA, Founding Partner and CEO, Almeda Ventures